Literature DB >> 11165308

Neuropeptide Y in male and female brains of Flinders Sensitive Line, a rat model of depression. Effects of electroconvulsive stimuli.

P A Jiménez-Vasquez1, D H Overstreet, A A Mathé.   

Abstract

Human and animal studies suggest that neuropeptide Y (NPY), a peptide co-localized and co-released with classical neurotransmitters, is involved in the pathogenesis of affective disorders. In addition, lithium, electroconvulsive treatments (ECT in humans and ECS in rodents) and antidepressants affect NPY in a specific temporal- and brain-region fashion. These results have been obtained on healthy male rats; females and/or "depressed" animals have essentially not been studied. Consequently, we studied brain NPY-like immunoreactivity (-LI) under basal conditions and following a series of ECS in both male and female Flinders Sensitive Line (FSL), an animal model of depression, and their controls, the Flinders Resistant Line (FRL) rats. Furthermore, we examined whether the oestrus cycle affects NPY-LI in these strains. Following sacrifice by focused microwave irradiation, the peptides were extracted from dissected brain regions and measured by radioimmunoassay. Hippocampal NPY-LI in both sexes was significantly lower in the "depressed" FSL compared to the control FRL. ECS increased NPY-LI in both male and female rats in both FSL and FRL strains in hippocampus, frontal cortex and occipital cortex. In the hypothalamus, the increase was found only in the FSL rats. In both FSL and control rats, the basal NPY-LI was lower in the hippocampus of female compared to male rats. NPY-LI did not vary during the different phases of the oestrus cycle. These results suggest that the gender differences are not due to NPY-LI variations during the oestrus. The results are consistent with our hypothesis that NPY plays a role in the pathophysiology of depressive disorders and provide further evidence that one of the modes of ECS action is to elevate NPY in the limbic system. Assumption that gender differences in NPY could explain increased rates of depression in women is speculative, but is in line with the findings in the present study.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11165308     DOI: 10.1016/s0022-3956(00)00036-4

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  14 in total

1.  Neuropeptide expression in rats exposed to chronic mild stresses.

Authors:  Valeriy Sergeyev; Serguei Fetissov; Aleksander A Mathé; Patricia A Jimenez; Tamas Bartfai; Patrick Mortas; Laurent Gaudet; Jean-Luc Moreau; Tomas Hökfelt
Journal:  Psychopharmacology (Berl)       Date:  2004-10-30       Impact factor: 4.530

Review 2.  Running is rewarding and antidepressive.

Authors:  Stefan Brené; Astrid Bjørnebekk; Elin Aberg; Aleksander A Mathé; Lars Olson; Martin Werme
Journal:  Physiol Behav       Date:  2007-05-21

3.  Prepartum fatty acid supplementation in sheep. III. Effect of eicosapentaenoic acid and docosahexaenoic acid during finishing on performance, hypothalamus gene expression, and muscle fatty acids composition in lambs.

Authors:  Ana Cristina Carranza Martin; Danielle Nicole Coleman; Lyda Guadalupe Garcia; Cecilia C Furnus; Alejandro E Relling
Journal:  J Anim Sci       Date:  2018-12-03       Impact factor: 3.159

4.  Altered function of peripheral organ systems in rats exposed to chronic mild stress model of depression.

Authors:  R Duncko; J Brtko; R Kvetnanský; D Jezová
Journal:  Cell Mol Neurobiol       Date:  2001-08       Impact factor: 5.046

5.  The influence of infant-caregiver experiences on amygdala Bdnf, OXTr, and NPY expression in developing and adult male and female rats.

Authors:  Kathryn T Hill; Megan Warren; Tania L Roth
Journal:  Behav Brain Res       Date:  2014-07-08       Impact factor: 3.332

6.  Rapid effects of S-ketamine on the morphology of hippocampal astrocytes and BDNF serum levels in a sex-dependent manner.

Authors:  Maryam Ardalan; Betina Elfving; Ali H Rafati; Monireh Mansouri; Carlos A Zarate; Aleksander A Mathe; Gregers Wegener
Journal:  Eur Neuropsychopharmacol       Date:  2020-01-20       Impact factor: 4.600

7.  Allele-specific programming of Npy and epigenetic effects of physical activity in a genetic model of depression.

Authors:  P A Melas; A Lennartsson; H Vakifahmetoglu-Norberg; Y Wei; E Åberg; M Werme; M Rogdaki; M Mannervik; G Wegener; S Brené; A A Mathé; C Lavebratt
Journal:  Transl Psychiatry       Date:  2013-05-07       Impact factor: 6.222

8.  Glycogen synthase kinase-3 regulates IGFBP-1 gene transcription through the thymine-rich insulin response element.

Authors:  David Finlay; Satish Patel; Lorna M Dickson; Natalia Shpiro; Rodolfo Marquez; Chris J Rhodes; Calum Sutherland
Journal:  BMC Mol Biol       Date:  2004-09-06       Impact factor: 2.946

9.  Targeting the Neuropeptide Y System in Stress-related Psychiatric Disorders.

Authors:  Nicole M Enman; Esther L Sabban; Paul McGonigle; Elisabeth J Van Bockstaele
Journal:  Neurobiol Stress       Date:  2015-01-01

10.  Antidepressant-like activity of the neuropeptide Y Y5 receptor antagonist Lu AA33810: behavioral, molecular, and immunohistochemical evidence.

Authors:  Helena Domin; Bernadeta Szewczyk; Bartłomiej Pochwat; Monika Woźniak; Maria Śmiałowska
Journal:  Psychopharmacology (Berl)       Date:  2016-12-14       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.